CDKN2A and neoplasm: A recent study suggested that NMR-specific alternative reading frame (ARF) and the disruption of oncogene embryonic cell-expressed Ras (ERAS) regulate tumor resistance in NMR-induced pluripotent stem cells (NMR-iPSCs) [9].